European countries scramble to get Russian vaccine The European Medicines Agency (EMA) has begun talks with Russia’s Sputnik V coronavirus vaccine makers.
The European Medicines Agency (EMA) has announced that it has opened talks with Russia’s Sputnik V coronavirus vaccine maker.
According to an official of the European Union, which licenses drugs and vaccines for the bloc, the Russian vaccine developer has contacted the EMA and talks are underway.
Regulators will review data so far on the Russian vaccine proposal before publishing it and determine whether the Russian-made Sputnik V vaccine can be used by healthcare systems in EU member states. May or may not.
According to the head of the Russian Direct Investment Fund, Kirill Dmitriev, on October 22, the application for the approval of the European countries for the Russian vaccine was filed. He has suggested that there is a possibility that this Russian vaccine could also be developed in Germany.
Earlier this week, the Gamalya Center, which developed Sputnik V, announced that a recent analysis of data from clinical trials suggested that the Russian-made vaccine may be more effective than previously estimated.
In a tweet on its Twitter account, the team said that more than 95 percent of those who received a single dose of the Russian vaccine developed herd immunity against Covid-19.
#European #countries #scrambled #Russian #vaccine
